These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Comparison of the efficacy of 5% topical spironolactone gel and placebo in the treatment of mild and moderate acne vulgaris: a randomized controlled trial. Afzali BM; Yaghoobi E; Yaghoobi R; Bagherani N; Dabbagh MA J Dermatolog Treat; 2012 Feb; 23(1):21-5. PubMed ID: 20964565 [TBL] [Abstract][Full Text] [Related]
6. Facial contact dermatitis due to spironolactone in an anti-acne cream. Vincenzi C; Trevisi P; Farina P; Stinchi C; Tosti A Contact Dermatitis; 1993 Nov; 29(5):277-8. PubMed ID: 8112074 [No Abstract] [Full Text] [Related]
7. Spironolactone for the Treatment of Acne: A 4-Year Retrospective Study. Grandhi R; Alikhan A Dermatology; 2017; 233(2-3):141-144. PubMed ID: 28472793 [TBL] [Abstract][Full Text] [Related]
13. Allergic contact dermatitis from topical diclofenac in Solaraze gel. Kerr OA; Kavanagh G; Horn H Contact Dermatitis; 2002 Sep; 47(3):175. PubMed ID: 12492560 [No Abstract] [Full Text] [Related]
14. The efficacy and safety of amoxicillin, trimethoprim-sulfamethoxazole, and spironolactone for treatment-resistant acne vulgaris. Turowski CB; James WD Adv Dermatol; 2007; 23():155-63. PubMed ID: 18159900 [TBL] [Abstract][Full Text] [Related]
15. Contact sensitization by alternative topical medicaments containing plant extracts. The Dutch Contact Dermatoses Group. Bruynzeel DP; van Ketel WG; Young E; van Joost T; Smeenk G Contact Dermatitis; 1992 Oct; 27(4):278-9. PubMed ID: 1451514 [No Abstract] [Full Text] [Related]